97009404 - KNOA PHARMACEUTICALS

Information

• Trademark
• 97009404

• Source

• Serial Number

  97009404

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 02, 2021
  2 years ago

• Transaction Date

  December 21, 2023
  4 months ago

• Status Date

  December 19, 2023
  4 months ago

• Published for Opposition Date

  May 02, 2023
  a year ago

• Location Date

  June 27, 2023
  10 months ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  CASE, LEIGH CAROLINE

• Attorney Docket Number

  491396-00002

  Attorney Name

  Fara S. Sunderji

  Law Office Assigned Location Code

  M30

• Owners

  • Purdue Pharma L.P.

Case File Statements

• GS0051: A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists
• D10000: "PHARMACEUTICALS"
• GS0421: Pharmaceutical research and development

Case File Event Statements

• 12/21/2023 - 4 months ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/19/2023 - 4 months ago

  24 - SOU EXTENSION 1 GRANTED Type: EX1G

• 12/19/2023 - 4 months ago

  23 - SOU EXTENSION 1 FILED Type: EXT1

• 12/19/2023 - 4 months ago

  22 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/27/2023 - 10 months ago

  21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 5/2/2023 - a year ago

  20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/2/2023 - a year ago

  19 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/12/2023 - a year ago

  18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/27/2023 - a year ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/16/2023 - a year ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/16/2023 - a year ago

  15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 3/16/2023 - a year ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/16/2023 - a year ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/7/2023 - a year ago

  12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 12/27/2022 - a year ago

  11 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 12/15/2022 - a year ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/7/2022 - a year ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/7/2022 - a year ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/7/2022 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/14/2022 - a year ago

  6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 6/14/2022 - a year ago

  5 - PRIORITY ACTION E-MAILED Type: GPRA

• 6/14/2022 - a year ago

  4 - PRIORITY ACTION WRITTEN Type: CPRA

• 6/7/2022 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/15/2021 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/6/2021 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP